These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17174645)

  • 1. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.
    Elkayam U; Tasissa G; Binanay C; Stevenson LW; Gheorghiade M; Warnica JW; Young JB; Rayburn BK; Rogers JG; DeMarco T; Leier CV
    Am Heart J; 2007 Jan; 153(1):98-104. PubMed ID: 17174645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.
    Shlipak MG; Smith GL; Rathore SS; Massie BM; Krumholz HM
    J Am Soc Nephrol; 2004 Aug; 15(8):2195-203. PubMed ID: 15284305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.
    Peacock WF; Hollander JE; Diercks DB; Lopatin M; Fonarow G; Emerman CL
    Emerg Med J; 2008 Apr; 25(4):205-9. PubMed ID: 18356349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
    Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS
    J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
    Gheorghiade M; Rossi JS; Cotts W; Shin DD; Hellkamp AS; Piña IL; Fonarow GC; DeMarco T; Pauly DF; Rogers J; DiSalvo TG; Butler J; Hare JM; Francis GS; Stough WG; O'Connor CM
    Arch Intern Med; 2007 Oct; 167(18):1998-2005. PubMed ID: 17923601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.
    Lee DS; Ghosh N; Floras JS; Newton GE; Austin PC; Wang X; Liu PP; Stukel TA; Tu JV
    Circ Heart Fail; 2009 Nov; 2(6):616-23. PubMed ID: 19919987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early vasoactive drugs improve heart failure outcomes.
    Peacock WF; Emerman C; Costanzo MR; Diercks DB; Lopatin M; Fonarow GC
    Congest Heart Fail; 2009; 15(6):256-64. PubMed ID: 19925503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.